Entrada Therapeutics Inc (TRDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 76,444 | 91,052 | 93,286 | 72,482 | 67,837 |
| Marketable Securities | 178,415 | 205,304 | 233,552 | 281,530 | 314,678 |
| Receivables | 787 | 1,177 | 1,196 | 1,180 | 2,044 |
| TOTAL | $266,872 | $306,252 | $338,257 | $369,146 | $403,193 |
| Non-Current Assets | |||||
| PPE Net | 6,506 | 7,313 | 8,406 | 9,807 | 10,674 |
| Other Non-Current Assets | 62,140 | 63,813 | 66,235 | 69,830 | 72,612 |
| TOTAL | $68,646 | $71,126 | $74,641 | $79,637 | $83,286 |
| Total Assets | $335,518 | $377,378 | $412,898 | $448,783 | $486,479 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,930 | 2,289 | 3,166 | 1,857 | 2,188 |
| Accrued Expenses | 11,730 | 17,682 | 15,532 | 11,795 | 7,579 |
| TOTAL | $19,195 | $24,451 | $24,019 | $19,803 | $18,431 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 254 | 342 | 351 | 689 | 1,352 |
| Other Non-Current Liabilities | 45,469 | 46,794 | 48,050 | 49,281 | 50,487 |
| TOTAL | $45,469 | $46,794 | $48,163 | $49,475 | $50,788 |
| Total Liabilities | $64,664 | $71,245 | $72,182 | $69,278 | $69,219 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 38,821 | 38,284 | 38,219 | 38,037 | 37,953 |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -312,811 | -273,094 | -233,930 | -189,796 | -146,693 |
| Other shareholders' equity | 246 | 652 | 621 | 400 | 437 |
| TOTAL | $270,854 | $306,133 | $340,716 | $379,505 | $417,260 |
| Total Liabilities And Equity | $335,518 | $377,378 | $412,898 | $448,783 | $486,479 |